Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Peab in connection with the listing of Annehem Fastigheter
Mandate

Vinge has advised Peab in connection with the listing of Annehem Fastigheter

December 11, 2020 Banking and Finance Capital Markets and Public M&A Corporate Tax Real Estate and Construction

Vinge has advised Peab and Annehem Fastigheter in connection with the distribution of the shares in Annehem Fastigheter to the shareholders in Peab as well as the listing of Annehem Fastigheter’s B shares on Nasdaq Stockholm. The prospectus was published 2 December 2020 and the first day of trading on Nasdaq Stockholm was 11 December 2020.

Annehem Fastigheter is a growth-driven property company specialising in commercial, community service and residential properties in the Nordic growth regions of Stockholm, Skåne, Gothenburg as well as Helsinki and Oslo. Annehem Fastigheter’s property portfolio consists of 22 investment properties with a value of SEK 3,281 million and a lettable area of 184 thousand sqm.

Vinge’s team consisted of Charlotte Levin, Rikard Lindahl, Joel Magnusson, Linnea Petersson, Assur Badur, Kristoffer Larson, Vilhelm Rondahl, Louise Brorsson Salomon, Linn Adelwald, Henrik Wastenson and Victor Ericsson.

 

Related

Vinge advises Trianon in connection with directed share issue and tender offer for subordinated sustainable capital securities

 Vinge advises Fastighets Aktiebolaget Trianon (publ) in connection with a directed share issue of SEK 184 million and a tender offer for outstanding subordinated perpetual floating rate callable sustainable capital securities.
April 19, 2024

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

 Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024